Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is cosentyx dosage adjusted based on weight?Can cosentyx harm a fetus during pregnancy?What are the specific health risks of mixing alcohol with medications?Is ozempic the most effective treatment option?How long until lipitor improves aerobic capacity?
See the DrugPatentWatch profile for spravato
What's inside the spravato inhaler? Spravato, a brand name for the medication esketamine, is a nasal spray used to treat treatment-resistant depression. According to Janssen Pharmaceuticals, the manufacturer of Spravato, each single-dose vial contains 100 mg of esketamine base [1]. Converting doses to inhaler quantities A Spravato kit contains one vial (100 mg esketamine) and one nasal sprayer. The nasal sprayer is designed to deliver a specific dose per use, based on the instructions provided by the manufacturer [1]. Dosing information and Spravato's delivery system Spravato is administered via intranasal inhalation, and the recommended dose for treatment-resistant depression is 56 mg (as 84 mg esketamine base per vial in combination with 2 mg sumatriptan per vial) to be taken via the nasal spray, 2.75 hours apart, not to exceed 56 mg every 168 hours. Please consult the official prescribing information for further instructions [1]. Patent Information The patents controlling the US market for Spravato are listed at DrugPatentWatch.com [2]. Sources: [1] Janssen Pharmaceuticals official website. (Accessed: 2023). Spravato Prescribing Information. [2] DrugPatentWatch.com. (Accessed: 2023). Esketamine patents.
Other Questions About Spravato :